JURNAL READING

Diagnosis, Microbial Epidemiology,

andAntibiotic
Treatment of Acute Otitis Media in
Children
A Systematic Review
Disusun Oleh:
Selvi Sulistia Ningsih (H1A010041)
Suluh Bayu Waskito (H1A010027)
Pembimbing:
dr. Afif Rahmawan, Sp.THT M.Kes

PENDAHULUAN

TUJUAN

Untuk melakukan tinjauan sistematis pada diagnosis OMA, pengobatan, dan asosias

METODE
SELEKSI

Data diambil dari

Inklusi

Data Abstraksi

Dua peneliti (T.R.C.

PENILAIAN KUALITAS
Kriteria J

SINTESIS DATA

HASIL

OMA Diagnosis
gejala infeksi akut
bukti radang telinga tengah
adanya efusi dari telinga tengah

EPIDEMIOLOGI mikrobakteri OMA dan PCV 7

Ampisilin atau Amoksisilin vs

Placebo

Antibiotik Segera vs Antibiotik

Terlambat

Efek berbahaya jangka pendek

dari terapi Antibiotik

Efek merugikan dari Pengobatan

Antibiotik jangka panjang
Tidak satu pun dari studi yang
mengevaluasi tingkat efek samping
jangka panjang pengobatan
antibiotik, termasuk resistensi
antibiotik

Perbandingan Efektivitas
Antibiotik
Amoxicillin clavulanate lebih unggul dari cefaclor

Antibiotik Terkait Efek Samping

Efek
A
moxicillin
samping
clavulanate
yang sering
menghasilkan
terjadi padatingkat
pengobatan
lebih tinggi
ini
adalahdiare
untuk
DIARE
dari 1dosis ceftriaxone

KESIMPULAN
Temuan otoskopik sangat penting untuk diagnosis OMA yang akurat.

PREFERENCE

1. Daly KA, Brown JE, Lindgren BR, Meland MH, Le CT, Giebink GS.
Epidemiology of otitis media onset by six months of age. Pediatrics.
1999;103(6, pt 1): 1158-1166.
2. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates
for children and adolescents. JAMA. 2002;287(23):3096-3102.
3. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first
seven years of life in children in greater Boston: a prospective, cohort study. J
Infect Dis. 1989;160(1):83-94.
4. Soni A. Ear infections (otitis media) in children (0-17): use and
expenditures, 2006. Statistical Brief No. 228. Agency for Healthcare Research
and Quality Web site. http://www.meps.ahrq.gov/mepsweb
/data_files/publications/st228/stat228.pdf. December 2008. Accessed
September 20, 2010.
5. Simel DL, Rothman R, Keitz S. Update: otitis media, child. In: Simel DL,
Rennie D, eds. The Rational Clinical Examination: Evidence-Based Clinical
Diagnosis. New York, NY: McGraw-Hill; 2009.
http//www.jamaevidence.com/content/3484986. Accessed September 2,
2010.
6. Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for
respiratory infections. Cochrane Database Syst Rev. 2007;(3):CD004417.
7. Kozyrskyj AL, Hildes-Ripstein GE, Longstaffe SE, et al. Short course

9. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial

drugs for acute otitis media:metaanalysis of 5400 children from thirty-three
randomized trials. J Pediatr. 1994;124(3):355-367.
10. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute
otitis media in children. Cochrane Database Syst Rev. 2004;(1):CD000219.
11. Takata GS, Chan LS, Shekelle PG, Morton SC, Mason W, Marcy SM.
Evidence assessment of management of acute otitis media, I: the role of
antibiotics in treatment of uncomplicated acute otitis media.Pediatrics.
2001;108(2):239-247.
12. American Academy of Pediatrics Subcommittee on Management of Acute
Otitis Media. Diagnosis and management of acute otitis media. Pediatrics.
2004; 113(5):1451-1465.
13. Coco A, Vernacchio L, Horst M, Anderson A. Management of acute otitis
media after publication of the 2004 AAP and AAFP clinical practice guideline.
Pediatrics. 2010;125(2):214-220.
14. Southern California Evidence-based Practice Center. Management of
Acute Otitis Media, Update.Rockville, MD: Agency for Healthcare Research
and Quality; 2010.
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of
randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17
(1):1-12.
16. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a
measurement tool to assess the methodological quality of systematic
reviews.BMC Med Res Methodol. 2007;7:10.
17. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The
development of QUADAS: a tool for the quality assessment of studies of

20. Laird NM, Mosteller F. Some statistical methods for combining

experimental results. Int J Technol Assess Health Care. 1990;6(1):5-30.
21. Stata. Version 10 [computer program]. College Station, TX: StataCorp;
2007.
22. SaeedK,CoglianeseCL,McCormickDP,Chonmaitree T. Otoscopic and
tympanometric findings in acute otitis media yielding dry tap at
tympanocentesis. Pediatr Infect Dis J. 2004;23(11):1030-1034.
23. Legros JM, Hitoto H, Garnier F, Dagorne C, Dubin J, Fanello S. Reliability
of the diagnosis of acute otitis media by general practitioners [in French].
Arch Pediatr.2007;14(5):427-433.
24. Laine MK, Thtinen PA, Ruuskanen O, Huovinen P, Ruohola A. Symptoms
or symptom-based scores cannot predict acute otitis media at otitis-prone
age. Pediatrics. 2010;125(5):e1154-e1161.
25. Kontiokari T, Koivunen P, Niemel M, Pokka T, UhariM. Symptoms of
acute otitis media. Pediatr Infect Dis J. 1998;17(8):676-679.
26. Niemela M, Uhari M, Jounio-Ervasti K, Luotonen J, Alho OP, Vierimaa E.
Lack of specific symptomatology in children with acute otitis media. Pediatr
Infect Dis J. 1994;13(9):765-768.
27. Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis
media. Arch Pediatr Adolesc Med. 1995;149(1):26-29.
28. Ingvarsson L. Acute otalgia in childrenfindings and diagnosis. Acta
Paediatr Scand. 1982;71(5): 705-710.
29. Karma PH, Penttil MA, Sipil MM, Kataja MJ. Otoscopic diagnosis of
middle ear effusion in acute and non-acute otitis media, I: the value of
different otoscopic findings. Int J Pediatr Otorhinolaryngol.1989;17(1):37-49.

31. Block SL, Hedrick J, Harrison CJ, et al. Communitywide vaccination with
the heptavalent pneumococcal conjugate significantly alters the
microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23 (9):829-833.
32. McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to
penicillin-nonsusceptible Streptococcus pneumoniae before and after the
introduction of the pneumococcal conjugate vaccine. Clin Infect Dis.
2005;40(12):1738-1744.
33. Brook I, Gober AE. Bacteriology of spontaneously draining acute otitis
media in children before and after the introduction of pneumococcal
vaccination.Pediatr Infect Dis J. 2009;28(7):640-642.
34. Eskola J, Kilpi T, Palmu A, et al; Finnish Otitis Media Study Group. Efficacy
of a pneumococcal conjugate vaccine against acute otitis media. N Engl
JMed. 2001;344(6):403-409.
35. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate
pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on
recurrent acute otitis media: a randomised study. Lancet. 2003;
361(9376):2189-2195.
36. Marcy M, Takata G, Chan LS, et al. Management of Acute Otitis Media:
Evidence Report/Technology Assessment No. 15. Rockville, MD: Agency for
Healthcare Research and Quality; 2001. Publication 01-E010.
37. van Buchem FL, Dunk JH, vant Hof MA. Therapy of acute otitis media:
myringotomy, antibiotics, or neither? a double-blind study in children.
Lancet. 1981; 2(8252):883-887.
38. Halsted C, Lepow ML, Balassanian N, Emmerich J, Wolinsky E. Otitis
media: microbiology and evaluation of therapy. Ann N Y Acad Sci. 1967;145

40. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus
separate components in otitis media: effectiveness of erythromycin
estrolate, triple sulfonamide, ampicillin, erythromycin estolate-triple
sulfonamide, and placebo in 280 patients with acute otitis media under two
and one-half years of age. Clin Pediatr (Phila). 1972;11(4):205-214.
41. Burke P, Bain J, Robinson D, Dunleavey J. Acute red ear in children:
controlled trial of non-antibiotic treatment in general practice. BMJ.
1991;303(6802):558-562.
42. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or
myringotomy or both for acute otitis media: results of a randomized clinical
trial. Pediatrics. 1991;87(4):466-474.
43. Damoiseaux RA, van Balen FA, Hoes AW, Verheij TJ, de Melker RA.
Primary care based randomised, double blind trial of amoxicillin versus
placebo for acute otitis media in children aged under 2 years. BMJ. 2000;
320(7231):350-354.
44. Le Saux N, Gaboury I, Baird M, et al. A randomized, double-blind,
placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed
acute otitis media in children 6 months to 5 years of age. CMAJ.
2005;172(3):335-341.
45. Little P, Moore M, Warner G, Dunleavy J, Williamson I. Longer term
outcomes from a randomised
trial of prescribing strategies in otitis media. Br J Gen Pract.
2006;56(524):176-182.
46. Little P, Gould C,Williamson I, MooreM, Warner G, Dunleavey J. Pragmatic
randomised controlled trial

48. Neumark T, Mlstad S, Rose n C, et al. Evaluation of

phenoxymethylpenicillin treatment of acute otitis media in children aged 2-16.
Scand J Prim Health Care. 2007;25(3):166-171.
49. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis
media: a clinical trial comparing outcomes of watchful waiting versus
immediate antibiotic treatment. Pediatrics. 2005;115(6):1455- 1465.
50. Bartlett JG. Clinical practice: antibioticassociated diarrhea. N Engl J Med.
2002;346(5): 334-339.
51. Adcock BB, Rodman DP. Ampicillin-specific rashes. Arch Fam Med.
1996;5(5):301-304.
52. Geyman JP, Erickson S. The ampicillin rash as a diagnostic and
management problem: case reports and literature review. J Fam Pract.
1978;7(3):493-496.
53. deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents.
JAMA. 1997;278(22):1895-1906.
54. Berman S, Lauer BA. A controlled trial of cefaclor versus amoxicillin for
treatment of acute otitis media in early infancy. Pediatr Infect Dis.
1983;2(1):30-33.
55. Casellas JMJ Jr, Israele V, Marn M, et al. Amoxicillin-sulbactam versus
amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media
in Argentinean children. Int J Pediatr Otorhinolaryngol. 2005;69(9):1225-1233.
56. McLinn SE. Cefaclor in treatment of otitis media and pharyngitis in children.
Am J Dis Child. 1980; 134(6):560-563.
57. Leigh AP, Robinson D, Millar ED. A general practice comparative study of a
new third-generation oral cephalosporin, cefixime, with amoxycillin in the

59. Kara CO, Ozuer MZ, Kilic I, Yalcin AN, Ergin H. Comparison of amoxicillin with second
and third generation cephalosporins in the treatment of acute otitis media. Infez Med.
1998;6(2):93-95.
60. Jacobson JA, Metcalf TJ, Parkin JL, Wenerstrom LG, Matsen JM. Evaluation of cefaclor
and amoxycillin in the treatment of acute otitis media. Postgrad Med J. 1979;55(suppl
4):39-41.
61. Subba Rao SD, Macias MP, Dillman CA, Ramos BD, Kierszenbaum JS, Soliman AE;
Augmentin 415 Study Group. A randomized, observer-blind trial of amoxicillin/clavulanate
versus cefaclor in the treament of children with acute otitis media. J Chemother.
1998;10(6):460-468.
62. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of
amoxicillin/ clavulanate vs. azithromycin in acute otitis media.Pediatr Infect Dis J.
2000;19(2):95-104.
63. Cohen R, Levy C, Boucherat M, Langue J, de La Rocque F. A multicenter, randomized,
doubleblind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young
children. J Pediatr. 1998;133(5):634-639.
64. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence
of diarrhea from a new formulation of amoxicillin/ clavulanate potassium (Augmentin) for
treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16(5):463-470.
65. Simon MW. Five- vs 10-day treatment of acute otitis media with ceftibuten in infants
and children. Adv Ther. 1997;14(6):312-317.
66. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing
acute otitis media six to eight years after introduction of pneumococcal conjugate
vaccine. Pediatr Infect Dis J. 2010;29(4):304-309.
67. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope.
2003;113 (10):1645-1657.
68. Berlin JA; University of Pennsylvania Metaanalysis Blinding Study Group. Does
blinding of readers affect the results of meta-analyses? Lancet. 1997;350(9072):185-186.
69. Pichichero ME, Casey JR. Diagnostic inaccuracy and subject exclusions render
placebo and observational studies of acute otitis media inconclusive.Pediatr Infect Dis J.

TERIMAKA
SIH